Masakatsu Motomura

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis

Osamu Higuchi, Johko Hamuro, Masakatsu Motomura et al. · Annals of Neurology · 2010 · 538 citations · Full text

Immunoglobulin G1, Molecular Physiology, Autoimmune Disease +12

The Muscle Protein Dok-7 Is Essential for Neuromuscular Synaptogenesis

Kumiko Okada, Akane Inoue, Momoko Okada et al. · Science · 2006 · 425 citations

Muscle-specific Receptor Kinase, Developmental Biology, Molecular Neuroscience +15

Dok-7 Mutations Underlie a Neuromuscular Junction Synaptopathy

David Beeson, Osamu Higuchi, Jackie Palace et al. · Science · 2006 · 267 citations

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.

Masakatsu Motomura, I Johnston, Bethan Lang et al. · Journal of Neurology Neurosurgery & Psychiatry · 1995 · 257 citations · Full text

Allergy, Serum Samples, Improved Diagnostic Assay +15